Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE) 1994

J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
Service d'Epidémiologie et Hygiène Hospitalière, CHU, Rennes, France.

The hemochromatosis gene (HFE) maps to 6p21.3 and is less than 1 cM from the HLA class I genes; however, the precise physical location of the gene has remained elusive and controversial. The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease. For these practical considerations, traditional linkage analysis could prove of limited value in further refining the extrapolated physical position of HFE. We therefore embarked upon a linkage-disequilibrium analysis of HFE and normal chromosomes from the Brittany population. In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.7 and HLA-F loci located 150 and 250 kb telomeric to HLA-A, respectively. The results suggest a strong peak of existing linkage disequilibrium focused within the i82-to-6.7 interval (approximately 250 kb). The zone of linkage disequilibrium is flanked by the i97 locus, positioned 30 kb proximal to i82, and the HLA-F gene, found 250 kb distal to HLA-A, markers of which display no significant association with HFE. These data support the possibility that HFE resides within the 400-kb expanse of DNA between i97 and HLA-F. Alternatively, the very tight association of HLA-A3 and allele 1 of the 6.7 locus, both of which are comprised by the major ancestral or founder HFE haplotype in Brittany, supports the possibility that the disease gene may reside immediately telomeric to the 6.7 locus within the linkage-disequilibrium zone. Additionally, hemochromatosis haplotypes possessing HLA-A11 and the low-frequency HLA-F polymorphism (allele 2) are supportive of a separate founder chromosome containing a second, independently arising mutant allele. Overall, the establishment of a likely "hemochromatosis critical region" centromeric boundary and the identification of a linkage-disequilibrium zone both significantly contribute to a reduction in the amount of DNA required to be searched for novel coding sequences constituting the HFE defect.

UI MeSH Term Description Entries
D008297 Male Males
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002896 Chromosomes, Human, Pair 6 A specific pair GROUP C CHROMSOMES of the human chromosome classification. Chromosome 6
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006432 Hemochromatosis A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed) Diabetes, Bronze,Bronze Diabetes,Bronzed Cirrhosis,Familial Hemochromatosis,Genetic Hemochromatosis,Haemochromatosis,Hemochromatoses,Iron Storage Disorder,Pigmentary Cirrhosis,Primary Hemochromatosis,Troisier-Hanot-Chauffard Syndrome,Von Recklenhausen-Applebaum Disease,Bronzed Cirrhoses,Cirrhoses, Bronzed,Cirrhoses, Pigmentary,Cirrhosis, Bronzed,Cirrhosis, Pigmentary,Disease, Von Recklenhausen-Applebaum,Diseases, Von Recklenhausen-Applebaum,Disorder, Iron Storage,Disorders, Iron Storage,Familial Hemochromatoses,Genetic Hemochromatoses,Haemochromatoses,Hemochromatose,Hemochromatoses, Familial,Hemochromatoses, Genetic,Hemochromatosis, Familial,Hemochromatosis, Genetic,Iron Storage Disorders,Pigmentary Cirrhoses,Recklenhausen-Applebaum Disease, Von,Recklenhausen-Applebaum Diseases, Von,Storage Disorder, Iron,Storage Disorders, Iron,Syndrome, Troisier-Hanot-Chauffard,Syndromes, Troisier-Hanot-Chauffard,Troisier Hanot Chauffard Syndrome,Troisier-Hanot-Chauffard Syndromes,Von Recklenhausen Applebaum Disease,Von Recklenhausen-Applebaum Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens

Related Publications

J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
September 1994, American journal of human genetics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
January 1996, Human genetics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
March 1990, Proceedings of the National Academy of Sciences of the United States of America,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
February 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
December 1995, American journal of human genetics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
March 2017, Briefings in bioinformatics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
May 2001, The American journal of gastroenterology,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
October 2002, BMC medical genetics,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
December 1996, Human immunology,
J Yaouanq, and M Perichon, and M Chorney, and P Pontarotti, and A Le Treut, and A el Kahloun, and V Mauvieux, and M Blayau, and A M Jouanolle, and B Chauvel
January 1989, Progress in clinical and biological research,
Copied contents to your clipboard!